Drug Profile
Erlizumab
Alternative Names: Anti-CD18 monoclonal antibody - Genentech; rhuMAb CD18Latest Information Update: 22 Mar 2001
Price :
$50
*
At a glance
- Originator Genentech
- Developer Genentech; PDL BioPharma; Roche
- Class Monoclonal antibodies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myocardial infarction; Shock